Travere Therapeutics
TVTX
TVTX
168 hedge funds and large institutions have $1.7B invested in Travere Therapeutics in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 60 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding
Funds holding: 168 → 168 (0)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
16% less capital invested
Capital invested by funds: $2.03B → $1.7B (-$327M)
Holders
168
Holding in Top 10
8
Calls
$4.43M
Puts
$2.43M
Top Buyers
| 1 | +$22.7M | |
| 2 | +$17.8M | |
| 3 | +$17.6M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$16.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$15.8M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$11.1M | |
| 3 | -$9.86M | |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$8.39M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$8.05M |